The anti-inflammatory potential of berberine in vitro and in vivo

Kuo, Chi-Li, Chi, Chin-Wen, Liu, Tsung-Yun·2004·Cancer Letters

DOI 10.1016/j.canlet.2003.09.002

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2003.09.002

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I
Turner, N., Li, J.-Y., Gosby, A., To, S. W. C., Cheng, Z., Miyoshi, H., Taketo, M. M., Cooney, G. J., Kraegen, E. W., James, D. E., et al. (2008) · Diabetes · doi:10.2337/db07-1552 · Cited by 535
Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats
Liu, Y.-T., Hao, H.-P., Xie, H.-G., Lai, L., Wang, Q., Liu, C.-X., & Wang, G.-J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033936 · Cited by 356
Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects
Spinozzi, S., Colliva, C., Camborata, C., Roberti, M., Ianni, C., Neri, F., Calvarese, C., Lisotti, A., Mazzella, G., & Roda, A. (2014) · Journal of Natural Products · doi:10.1021/np400607k · Cited by 161
Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions
Pereira, G. C., Branco, A. F., Matos, J. A. C., Pereira, S. L., Parke, D., Perkins, E. L., Serafim, T. L., Sardão, V. A., Santos, M. S., Moreno, A. J. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128017 · Cited by 152
Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Ju, J., Li, J., Lin, Q., & Xu, H. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.212 · Cited by 124
MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth
Lo, T.-F., Tsai, W.-C., & Chen, S.-T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075628 · Cited by 122
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854885 · Cited by 69
“In recent years, a large number of research confirmed that BBR has extensive pharmacological properties, such as anti-inflammatory (Kuo et al., 2004), pain‐relieving (Hashemzaei and Rezaee, 2021), anti-infective (Aswathanarayan and Vittal, 2018), antitumor (Liu et al.”
Background
Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p
Tong, Y., Zhang, J., Sun, N., Wang, X.-M., Wei, Q., Zhang, Y., Huang, R., Pu, Y., Dai, H., Ren, B., et al. (2021) · Science Bulletin · doi:10.1016/j.scib.2020.12.035 · Cited by 70
Syntheses and Structure–Activity Relationships in Growth Inhibition Activity against Human Cancer Cell Lines of 12 Substituted Berberine Derivatives
Wang, B., Deng, A.-J., Li, Z.-H., Wang, N., & Qin, H.-L. (2020) · Molecules · doi:10.3390/molecules25081871 · Cited by 23
Quasi-Irreversible Inhibition of CYP2D6 by Berberine
Kim, H. G., Lee, H. S., Jeon, J. S., Choi, Y. J., Choi, Y. J., Yoo, S.-Y., Kim, E.-Y., Lee, K., Park, I., Na, M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100916 · Cited by 21
Prospective performance evaluation of selected common virtual screening tools, case study: cyclooxygenase (COX) 1 and 2.
Kaserer, T., Temml, V., Kutil, Z., Vanek, T., Landa, P., & Schuster, D. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.017 · Cited by 23

Authors: Kuo, C.-L., Chi, C.-W., & Liu, T.-Y.
Venue: Cancer Letters
Publisher: Elsevier BV
Published: 2004-01
Volume: 203
Issue: 2
Pages: 127-137
ISSN: 0304-3835 (ISSN-L)
DOI: 10.1016/j.canlet.2003.09.002
OpenAlex: W1994153742
Cited by: 685
References: 0
FWCI: 5.79
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review